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are characteristic of B. procyonis 
roundworms and distinguish it from 
other nematodes that are known to 
affect humans (2,3). 
This case is unusual in several 
respects: the patient is the oldest 
known person with conﬁ  rmed  B. 
procyonis NLM; it is only the second 
case reported from Canada (5); and it 
is a pathologically proven example 
of cerebral B. procyonis infection 
in a human without major clinical 
manifestations. Although this patient’s 
dementia could have masked subtle 
neurologic features, no changes were 
witnessed by caregivers or relatives, 
and the patient voiced no concerns. 
Her long-standing dementia was 
fully explained by Alzheimer-type 
pathology, and it is highly unlikely that 
the low-level and restricted anatomic 
distribution of parasitic infection would 
have contributed to her dementia. More 
likely, the combination of confusion 
and poor hygiene and ambulatory state 
in the patient may have predisposed her 
to acquiring B. procyonis roundworms 
through ingestion of contaminated soil. 
The existence of mild or subclinical B. 
procyonis brain infection is recognized 
in veterinary medicine (1,2). This 
case expands the currently recognized 
spectrum of human disease caused by 
B. procyonis roundworms to include 
mild or subclinical cerebral infection 
in elderly persons and suggests that 
dementia may increase the risk for 
exposure.
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Dengue 
Surveillance among 
French Military in 
Africa 
To the Editor: In their recent 
article, Amarasinghe et al. (1) describe 
dengue virus distribution in Africa. 
Their data were based on published 
reports of dengue cases among local 
populations and travelers returning 
from Africa. To complement the 
description by Amarasinghe and 
colleagues of dengue serotypes found 
in Africa, we report results from 
dengue virologic testing during 1998–
2010. The tests were performed at the 
Arbovirus National Reference Center 
(Tropical Medicine Institute of the 
Military Health Service, Marseille, 
France).
Each year, ≈14,000 French soldiers 
are stationed in dengue-endemic areas 
of Africa (mainly Cameroon, Central 
African Republic, Chad, Djibouti, 
Gabon, Côte d’Ivoire, Senegal, and 
Mayotte and Reunion islands), from 
which they travel throughout Africa. 
The population of soldiers is under 
constant epidemiologic surveillance. 
If symptoms of dengue fever develop 
in a soldier, a blood sample and a 
dengue-speciﬁ   c questionnaire from 
the patient are sent to the Tropical 
Medicine Institute of the Military 
Health Service. Virus culture and 
reverse transcription PCR, or both, 
were performed on early samples; 
otherwise, serologic testing was 
performed by using in-house assays 
(IgM antibody capture ELISA and 
direct IgG ELISA).
During the 12 years of 
surveillance, the laboratory received 
2,423 samples from patients with 
suspected dengue within the French 
Armed Forces in Africa. Of these, 
224 were probable acute dengue 
infections: 202 had positive IgM 
serologic results for dengue, and 22 
were conﬁ   rmed as dengue cases by 
RT-PCR or culture (Table). Serologic 
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data may be confusing because of 
potential cross-reactions with other 
ﬂ  avivirus antibodies (in particular in 
Chad with West Nile virus).
Because of probable 
underreporting from the ﬁ  eld,  our 
reported number of conﬁ  rmed dengue 
cases likely underestimates the actual 
number of cases among French troops 
stationed in Africa. Nonetheless, our 
data complement those reported by 
Amarasinghe et al. by demonstrating 
additional locations for circulation 
of serotype 1 (Cameroon, Djibouti, 
Gabon, Mayotte) and serotype 3 
(Comoros). Military epidemiologic 
surveillance systems can detect 
dengue circulation where soldiers 
stay. Thus, these systems could 
serve to evaluate the risk for dengue 
infection in countries without local 
epidemiologic surveillance systems, 
thereby improving knowledge 
about dengue circulation in African 
countries.
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Clonal Spread of 
Mycoplasma 
pneumoniae in 
Primary School, 
Bordeaux, France
To the Editor:  Mycoplasma 
pneumoniae is responsible for ≈20% 
of all cases of community-acquired 
pneumonia. The most common form 
of the infection is tracheobronchitis, 
for which an etiologic diagnosis 
is seldom reached (1). Although 
tracheobronchitis is often mild, 
the infection is disruptive, with the 
cough lasting several weeks, and 
consumes substantial resources (2). 
M. pneumoniae infections occur 
endemically and epidemically 
worldwide, especially in children 
and young adults (1). In 2010, an 
increased incidence was reported from 
Denmark (3), England and Wales (4), 
and Israel (5). Several outbreaks have 
been reported in closed or semiclosed 
settings, as indicated on the basis 
of similar clinical symptoms, chest 
radiograph results, and detection of 
the bacteria (1). 
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Table. Countries in Africa with evidence of dengue virus transmission among French Armed Forces, 1998–2010 
Country and year  No. cases  Testing method  Infection status  Dengue virus serotype 
Cameroon, 2010  1  PCR  Confirmed  1 
Cape Verde, 2010  5  Culture  Confirmed  3 
Central African Republic, 1995  1  Serology  Probable  Unknown 
Chad, 1998–2001, 2003, 2006, 2009–2010  28  Serology  Probable  Unknown 
Comoros        
 2010  1  PCR,  culture  Confirmed    1 
 2010  2  PCR  Confirmed  3 
Côte d’Ivoire         
 1999  1  Culture  Confirmed  1 
 2000,  2004–2007  11  Serology  Probable  Unknown 
 2010  1  PCR  Confirmed  3 
Djibouti        
 1998  4  Culture  Confirmed  1 
 1998  24  Serology  Probable  Unknown 
 2000  2  Culture  Confirmed  1 
 2000  4  Serology  Probable  Unknown 
 2001–2005  123  Serology  Probable  Unknown 
 2005  1  PCR  Confirmed  ND 
 2006  4  Serology  Probable  Unknown 
 2008  2  Serology  Probable  Unknown 
Gabon        
 1998,  2006–2008  22  Serology  Probable  Unknown 
 2010  1  PCR  Confirmed  1 
Mayotte, 2009  1  Culture  Confirmed  1 
Senegal, 2009  1  PCR  confirmed  3 
Somalia, 1999  1  culture  confirmed  2 